Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.57 -0.19 (-0.52%)
As of: Sep 9, 2026 · 2:26 PM EDT

Teva Pharmaceutical Industries (TEVA) Change in Inventory (2025 - 2026)

Teva Pharmaceutical Industries' (TEVA) quarterly Change in Inventory came in at -$59.0 million in Q2 2026, up 3.28% on a YoY basis from -$57.1 million in Q2 2025, and up 36.56% quarter-over-quarter from -$93.0 million in Q1 2026.

Analysis

Teva Pharmaceutical Industries (TEVA) Change in Inventory (2025 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has reported Change in Inventory for 2 consecutive years, with -$59.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Inventory rose 3.28% year-over-year to -$59.0 million; the trailing twelve-month figure through Jun 2026 stood at -$333.0 million (changed N/A YoY), and the FY2025 full-year result was $152.0 million, down 8.43% from the prior year.
  • Change in Inventory rose to -$59.0 million in Q2 2026 per TEVA's latest filing, from -$93.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at -$59.0 million in Q2 2026 and bottomed at -$120.0 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn -59.00 Mn
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn 99.50 Mn
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn -76.69 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 69.19 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn 22.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -403,000.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -305,000.00
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn 9.88 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn -
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.00 Mn
Mar 31, 2026 -93.00 Mn
Jun 30, 2025 -61.00 Mn
Mar 31, 2025 -120.00 Mn